Healthcare -
Biotechnology - NASDAQ - US
$ 1.277
-5.41 %
$ 148 M
Market Cap
-14.19
P/E
CHRS - TOTAL LIABILITIES
Total Liabilities CHRS - Coherus BioSciences, Inc.
823 M
LAST VALUE
18.96%
2 YEAR CAGR
42.91%
5 YEAR CAGR
24.80%
10 YEAR CAGR